Focused Wealth Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-65
| Closed | -$81 | – | 205 |
|
|
2023
Q4 | $81 | Hold |
65
| – | – | ﹤0.01% | 956 |
|
|
2023
Q3 | $74 | Hold |
65
| – | – | ﹤0.01% | 959 |
|
|
2023
Q2 | $59 | Hold |
65
| – | – | ﹤0.01% | 975 |
|
|
2023
Q1 | $36 | Hold |
65
| – | – | ﹤0.01% | 990 |
|
|
2022
Q4 | $38 | Hold |
65
| – | – | ﹤0.01% | 1020 |
|
|
2022
Q3 | $0 | Hold |
65
| – | – | ﹤0.01% | 897 |
|
|
2022
Q2 | $0 | Hold |
65
| – | – | ﹤0.01% | 870 |
|
|
2022
Q1 | $0 | Hold |
65
| – | – | ﹤0.01% | 929 |
|
|
2021
Q4 | $0 | Hold |
65
| – | – | ﹤0.01% | 922 |
|
|
2021
Q3 | $0 | Hold |
65
| – | – | ﹤0.01% | 919 |
|
|
2021
Q2 | $0 | Buy |
+65
| New | – | ﹤0.01% | 851 |
|